Metabolic (dysfunction)-associated fatty liver disease (MAFLD) is the most common chronic
liver disease worldwide–with an estimated global prevalence of 37%. Different from …

Metabolic dysfunction–associated fatty liver disease (MAFLD) has appeared as the leading
liver disease worldwide. Whereas the terminology nonalcoholic fatty liver disease (NAFLD) …

The gut microbiota was reported to play a significant role in the progression of the metabolic
associated fatty liver disease (MAFLD). Our recent study suggested that gastrointestinal tract …

To the editor, We read with interest the paper by Younossi et al.[1] on the differential impact
of nonalcoholic fatty liver disease (NAFLD) and metabolic dysfunction associated fatty liver …

Abstract Background and Aim This study aims to validate the efficacy of the conventional
non-invasive score in predicting significant fibrosis in metabolic-associated fatty liver …

Introduction: Metabolic associated fatty liver disease (MAFLD), the nomenclature major
benefit is the shift towards a diagnosis of inclusion based on the presence of metabolic …

The literature review deals with the problem of metabolic dysfunction-associated fatty liver
disease that is poorly studied in pediatric gastroenterology. Until recently, primary hepatic …

Літературний огляд присвячений недостатньо вивченій у дитячій гастроентерології
проблемі метаболічно асоційованої жирової хвороби печінки. До недавнього часу …